Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00560248 · ClinicalTrials.gov registry record
The BEACON Registry: Best Expert Agreement for Care of Occult Myocardial Infarction (MI) Nationally
A clinical trial, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- 1,897
- Enrollment target
NCT00560248: Clinical Trial study, sponsored by The Cleveland Clinic.
NCT00560248 is a clinical trial that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 1,897 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00560248 was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- 1,897 participants
- Enrollment target
Study Summary
The purpose of this registry is to assess and improve the process of care and health outcomes of patients presenting to the Emergency Department with chest pain suspected to be of cardiac origin. The study will identify which methods facilitate the diagnosis and risk stratification of ST elevation myocardial infarction (STEMI) or non STEMI, including patients with occult myocardial infarction (MI), and result in a shorter time to definitive diagnosis and treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,897 participants |
| Start Date | 2007-11 |
| Est. Completion | 2009-09 |
Why NCT00560248 stopped before completion
NCT00560248 is an observational study that tracks outcomes without assigning an intervention. Its 1,897 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00560248 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00560248 about?
NCT00560248 is a clinical study titled "The BEACON Registry: Best Expert Agreement for Care of Occult Myocardial Infarction (MI) Nationally". The purpose of this registry is to assess and improve the process of care and health outcomes of patients presenting to the Emergency Department with chest pain suspected to be of cardiac origin. The study will identify which methods facilitate the diagnosis and risk stratification of ST elevation m...
What is the current status of trial NCT00560248?
This trial is currently terminated. The enrollment target is 1,897 participants. The study started on 2007-11. Estimated completion is 2009-09.
Who is sponsoring clinical trial NCT00560248?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07308717 · 1,896 participants · Phase 4
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol
- NCT03729180 · 1,900 participants · NA
The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery
- NCT05712200 · 1,900 participants · Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- NCT06929806 · 1,900 participants · Phase 3
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia